Authors

    Language

    English

    Publication Date

    11-1-2025

    Journal

    Journal of Clinical Oncology

    DOI

    10.7759/cureus.96824

    PMID

    41404236

    PMCID

    PMC12703646

    PubMedCentral® Posted Date

    11-14-2025

    PubMedCentral® Full Text Version

    Post-print

    Abstract

    This systematic review comprehensively evaluates current evidence on molecular and biochemical biomarkers for predicting recurrence and prognosis in bladder cancer. A literature search was conducted across PubMed, Scopus, and Web of Science databases up to September 2025, identifying 347 records. After rigorous screening and eligibility assessment, five studies met the inclusion criteria. The included research encompassed a range of biomarker types, including circulating tumor DNA (ctDNA), immune infiltration markers, methylation signatures, systemic inflammatory indices, and gene expression-based predictive models such as COXEN. Despite heterogeneity in study designs, methodologies, and endpoints, consistent findings indicated that integrated molecular profiling substantially improves the prediction of recurrence and disease progression beyond conventional clinicopathologic parameters. Immune and genomic biomarkers showed strong potential for early detection of relapse, while methylation and enzymatic markers provided additional prognostic stratification. Although most studies demonstrated a moderate risk of bias due to exploratory or non-randomized designs, the overall methodological quality was acceptable. The findings underscore the clinical utility of biomarker-guided surveillance and personalized management strategies in bladder cancer, while highlighting the need for large-scale validation and standardization of biomarker assays in future research.

    Keywords

    biomarkers, bladder cancer, coxen, ctdna, immune markers, methylation, molecular profiling, predictive models, prognosis, recurrence

    Published Open-Access

    yes

    Share

    COinS
     
     

    To view the content in your browser, please download Adobe Reader or, alternately,
    you may Download the file to your hard drive.

    NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.